COO — The Cooper Companies Inc. stock price and chart

COO

The Cooper Companies Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · Nasdaq Composite 0.02% · S&P 500 0.02% · Russell 3000 0.02% · Russell 1000 0.02% · US Stock Market 0.02% · MSCI ACWI 0.01% · MSCI World 0.01%

$55.29+2.81%

as of market close, Sep 18, 2026

☾ AH $55.29 +0.00%

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDS

20162019202120242026

40.050.060.070.080.090.0100.0110.0020.0M40.0M$55.29

2026-09-18

Price$55.29

MA20$67.21

MA50$71.85

Vol24.2M

What would $1,000 invested in COO be worth today? →

COO returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $55.29
Change YTD: -32.54%
Market cap: 10.5B2016-09 8.7B2026-09 10.5B+20.3% over the window
Enterprise value: 13.2B
Shares outstanding: 190.2M2016-07 195M2026-07 190.2M-2.5% over the window
52W low: $51.01
52W high: $89.83
From 52W high: -38.45%
From 52W low: +8.39%
52W range: 11%
Beta: 0.82

Volume

Rel volume: 2.59×
30D volume: 3.4M
30D $ vol: 210.7M

Fundamentals

Sales (ttm): 4.2B2016-07 1.9B2026-07 4.2B+122.6% over the window
Sales/share: $22.282016-07 $9.762026-07 $22.28+128.2% over the window
EPS (ttm): $2.912016-07 $1.282026-07 $2.91+128.0% over the window
FCF (ttm): 678M2016-07 245.1M2026-07 678M+176.7% over the window
FCF/share: $3.572016-07 $1.262026-07 $3.57+183.7% over the window
Book value/share: $43.802016-07 $14.012026-07 $43.80+212.7% over the window
Net margin: 13.46%2016-07 13.1%2026-07 13.5%+2.5% over the window
ROE: 6.85%2016-07 9.2%2026-07 6.8%-25.2% over the window
ROA: 4.50%2016-07 5.4%2026-07 4.5%-17.4% over the window
Debt / equity: 0.23×2016-07 0.522026-07 0.23-55.6% over the window
Current ratio: 1.222016-07 2.902026-07 1.22-57.9% over the window

Growth (CAGR, ttm) · 10Y

Sales: +4.73%2025-07-31 → 2026-07-314B → 4.2B (+4.7% total)+6.43%2023-07-31 → 2026-07-313.5B → 4.2B (+20.6% total)+8.29%2021-07-31 → 2026-07-312.8B → 4.2B (+48.9% total)+8.33%2016-07-31 → 2026-07-311.9B → 4.2B (+122.6% total)
Net income: +39.88%2025-07-31 → 2026-07-31407.8M → 570.3M (+39.8% total)+27.47%2023-07-31 → 2026-07-31275.3M → 570.3M (+107.2% total)-27.85%2021-07-31 → 2026-07-312.9B → 570.3M (-80.4% total)+8.59%2016-07-31 → 2026-07-31250.1M → 570.3M (+128.0% total)
FCF: +64.66%2025-07-31 → 2026-07-31411.9M → 678M (+64.6% total)+45.16%2023-07-31 → 2026-07-31221.6M → 678M (+206.0% total)+5.21%2021-07-31 → 2026-07-31526M → 678M (+28.9% total)+10.71%2016-07-31 → 2026-07-31245.1M → 678M (+176.7% total)
Shares: -4.36%2025-07-31 → 2026-07-31198.8M → 190.2M (-4.4% total)-1.35%2023-07-31 → 2026-07-31198.1M → 190.2M (-4.0% total)-0.73%2021-07-31 → 2026-07-31197.2M → 190.2M (-3.6% total)-0.25%2016-07-31 → 2026-07-31195M → 190.2M (-2.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +43.33%2025-07-31 → 2026-07-31$2.03 → $2.91 (+43.3% total)+28.17%2023-07-31 → 2026-07-31$1.38 → $2.91 (+110.6% total)-27.63%2021-07-31 → 2026-07-31$14.67 → $2.91 (-80.1% total)+8.59%2016-07-31 → 2026-07-31$1.28 → $2.91 (+128.0% total)
Sales/share: +9.50%2025-07-31 → 2026-07-31$20.35 → $22.28 (+9.5% total)+7.89%2023-07-31 → 2026-07-31$17.74 → $22.28 (+25.6% total)+9.09%2021-07-31 → 2026-07-31$14.43 → $22.28 (+54.5% total)+8.60%2016-07-31 → 2026-07-31$9.76 → $22.28 (+128.2% total)
FCF/share: +72.16%2025-07-31 → 2026-07-31$2.07 → $3.57 (+72.1% total)+47.15%2023-07-31 → 2026-07-31$1.12 → $3.57 (+218.7% total)+5.98%2021-07-31 → 2026-07-31$2.67 → $3.57 (+33.7% total)+10.99%2016-07-31 → 2026-07-31$1.26 → $3.57 (+183.7% total)
Book value/share: +4.25%2025-07-31 → 2026-07-31$42.01 → $43.80 (+4.2% total)+4.84%2023-07-31 → 2026-07-31$38.00 → $43.80 (+15.2% total)+4.95%2021-07-31 → 2026-07-31$34.40 → $43.80 (+27.3% total)+12.08%2016-07-31 → 2026-07-31$14.01 → $43.80 (+212.7% total)
Dividend/share: -39.68%2023-07-31 → 2024-07-31$0.01 → $0.01 (-39.7% total)-20.88%2021-07-31 → 2024-07-31$0.02 → $0.01 (-50.5% total)-12.42%2019-07-31 → 2024-07-31$0.01 → $0.01 (-48.5% total)n/a
Price: -17.76%2025-09-18 → 2026-09-18$67.22 → $55.29 (-17.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-13.14%2023-09-18 → 2026-09-18$84.37 → $55.29 (-34.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-12.71%2021-09-17 → 2026-09-18$109.15 → $55.29 (-49.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.61%2016-09-16 → 2026-09-18$47.13 → $55.29 (+17.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -17.76%2025-09-18 → 2026-09-18$67.22 → $55.29 (-17.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-13.14%2023-09-18 → 2026-09-18$84.37 → $55.29 (-34.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-12.71%2021-09-17 → 2026-09-18$109.11 → $55.29 (-49.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.62%2016-09-16 → 2026-09-18$47.06 → $55.29 (+17.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 19.0×2016-09 34.942026-09 18.44-47.2% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 19.3×2016-09 29.902026-09 19.32-35.4% over the window
Fwd P/E: 11.6×
P/S (ttm)Market cap ÷ TTM revenue.: 2.5×2016-09 4.592026-09 2.48-45.9% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.3×2016-09 3.202026-09 1.26-60.5% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 15.5×2016-09 35.652026-09 15.51-56.5% over the window
EV/EBITDA (fy): 14.2×
EV/Sales (ttm): 3.1×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 6.45%2016-07 2.8%2026-07 4.8%+72.8% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-07-31) ÷ shares_at(2025-07-31) = 1 − 190.2M ÷ 198.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 4.36%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (4.36%) + dividends paid over that year ($0) ÷ market_cap_at(2025-07-31) ($14.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 4.36%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($644M) ÷ today's market cap ($10.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 6.13%2016-07 0.6%2026-07 4.6%+683.9% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $644M + TTM dividends $0) ÷ today's market cap ($10.5B). Same caveat as the cash buyback yield.: 6.13%2016-07 0.6%2026-07 4.6%+641.2% over the window

Vs own 10Y history

P/E: 13th
P/OI: 4th
P/S: 0th
P/B: 0th
P/FCF: 0th

Bar = where today’s multiple sits in COO’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-18

+2.81%

+2.56%

-27.02%

-16.11%

YTD

-32.54%

-17.75%

-49.34%

Financial statements

Open full COO financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-5.94%	+0.04%
JNJ	Johnson & Johnson	-0.41%	-0.09%
ABBV	AbbVie Inc.	+1.95%	-0.02%
MRK	Merck & Co. Inc.	+8.66%	-0.19%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.32%	+0.45%
TMO	Thermo Fisher Scientific Inc.	+10.60%	-1.04%
AMGN	Amgen Inc.	-9.32%	+1.55%
GILD	Gilead Sciences Inc.	+4.65%	-0.52%

The Cooper Companies Inc. (COO) trades at $55.29 with a live price and an interactive chart covering 42+ years of daily price history, plus key valuation metrics. ChartRow also publishes COO’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full COO financial statements →

COO — The Cooper Companies Inc. price, chart and key statistics